Form 4: Repligen Director Carrie Eglinton Manner Reports Stock and Option Awards

Carrie Eglinton Manner, a director at Repligen Corp, reported the acquisition of restricted stock units and stock options.

Summary

• On May 15, 2025, Carrie Eglinton Manner, a director of Repligen Corp, was awarded 973 restricted stock units, each representing a contingent right to receive one share of Repligen's common stock.
• These restricted stock units vest on the earlier of May 15, 2026, or the date of the next annual meeting of the company's shareholders.
• Manner also acquired 1,800 stock options with an exercise price of $123.26, which vest on the earlier of May 15, 2026, or the date of the next annual meeting of the company's shareholders and expire on May 15, 2035.
• Following these transactions, Manner directly owns 4,466 shares of Repligen's common stock and 1,800 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine stock and option awards to a director. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon future events, specifically the earlier of May 15, 2026, or the date of the next annual meeting of the company's shareholders, which has not yet been determined.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotechnology and pharmaceutical industries.
• Companies like Thermo Fisher Scientific, Danaher, and Sartorius also utilize similar equity-based compensation plans to align the interests of management and shareholders.

Stakeholder Impact

• The stock and option awards align the director's interests with those of the shareholders, potentially incentivizing actions that increase shareholder value.

Key Dates

Keywords

Repligen, Director, Stock Options, Restricted Stock Units, Form 4, Beneficial Ownership, Securities